_BAD-eSymposia | Tuberculosis: Science Aimed at Ending the Epidemic

Dec 2, 2020 ‐ Dec 4, 2020



Sessions

Taking Science‑Based Solutions to Scale

Oct 2, 2020 10:00am ‐ Oct 2, 2020 10:40am

Speaker(s):

Breakthroughs from Brazil and Beyond

Oct 2, 2020 10:40am ‐ Oct 2, 2020 11:05am

Speaker(s):

Can Host Blood Transcriptomic Biomarkers of Tuberculosis Inform Therapy?

Oct 2, 2020 11:05am ‐ Oct 2, 2020 11:30am

Speaker(s):

Short Talk: Immuno‑ and Transcriptomic Diagnostics for Leprosy

Oct 2, 2020 11:30am ‐ Oct 2, 2020 11:42am

Speaker(s):

Short Talk: Immune Correlates of Protection in Humans

Oct 2, 2020 11:42am ‐ Oct 2, 2020 11:54am

Speaker(s):

Short Talk: GPX4 and BACH1 Regulate Necrotic Cell Death and Host Resistance in Mycobacterium Tuberculosis Infection in vivo

Oct 2, 2020 11:54am ‐ Oct 2, 2020 12:06pm

Speaker(s):

Short Talk: Apparent Sterilizing Immunity in BCG‑Immunized Mice Challenged with an Ultra Low Dose of Mycobacterium tuberculosis

Oct 2, 2020 12:06pm ‐ Oct 2, 2020 12:18pm

Speaker(s):

Short Talk: Host Immune Regulator PARP1 Drives TB Sex Differences

Oct 2, 2020 12:18pm ‐ Oct 2, 2020 12:30pm

Speaker(s):

Short Talk: Genome‑to‑Genome Analysis Identifies the Effect of the Host Immune Systems on Mycobacterium Tuberculosis and Its Impact on Clinical Outcomes

Oct 2, 2020 12:30pm ‐ Oct 2, 2020 12:42pm

Speaker(s):

Can Basic Immunology Solve Tuberculosis?

Oct 2, 2020 5:00pm ‐ Oct 2, 2020 5:25pm

Speaker(s):
  • Alan Sher, PhD, NIAID, National Institutes of Health
Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content